Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 123


Cumulative incidence of false-positive test results in lung cancer screening: a randomized trial.

Croswell JM, Baker SG, Marcus PM, Clapp JD, Kramer BS.

Ann Intern Med. 2010 Apr 20;152(8):505-12, W176-80. doi: 10.7326/0003-4819-152-8-201004200-00007. Erratum in: Ann Intern Med. 2010 Jun 1;152(11):759.


Performance of Lung-RADS in the National Lung Screening Trial: a retrospective assessment.

Pinsky PF, Gierada DS, Black W, Munden R, Nath H, Aberle D, Kazerooni E.

Ann Intern Med. 2015 Apr 7;162(7):485-91. doi: 10.7326/M14-2086.


Results of initial low-dose computed tomographic screening for lung cancer.

National Lung Screening Trial Research Team, Church TR, Black WC, Aberle DR, Berg CD, Clingan KL, Duan F, Fagerstrom RM, Gareen IF, Gierada DS, Jones GC, Mahon I, Marcus PM, Sicks JD, Jain A, Baum S.

N Engl J Med. 2013 May 23;368(21):1980-91. doi: 10.1056/NEJMoa1209120.


National Lung Screening Trial findings by age: Medicare-eligible versus under-65 population.

Pinsky PF, Gierada DS, Hocking W, Patz EF Jr, Kramer BS.

Ann Intern Med. 2014 Nov 4;161(9):627-33. doi: 10.7326/M14-1484.


False-positive test results in a study of lung cancer screening.

[No authors listed]

Ann Intern Med. 2010 Apr 20;152(8):I40. doi: 10.7326/0003-4819-152-8-201004200-00003. No abstract available.


Reduced lung-cancer mortality with low-dose computed tomographic screening.

National Lung Screening Trial Research Team, Aberle DR, Adams AM, Berg CD, Black WC, Clapp JD, Fagerstrom RM, Gareen IF, Gatsonis C, Marcus PM, Sicks JD.

N Engl J Med. 2011 Aug 4;365(5):395-409. doi: 10.1056/NEJMoa1102873. Epub 2011 Jun 29.


Benefits and harms of computed tomography lung cancer screening strategies: a comparative modeling study for the U.S. Preventive Services Task Force.

de Koning HJ, Meza R, Plevritis SK, ten Haaf K, Munshi VN, Jeon J, Erdogan SA, Kong CY, Han SS, van Rosmalen J, Choi SE, Pinsky PF, Berrington de Gonzalez A, Berg CD, Black WC, Tammemägi MC, Hazelton WD, Feuer EJ, McMahon PM.

Ann Intern Med. 2014 Mar 4;160(5):311-20. doi: 10.7326/M13-2316.


Projected outcomes using different nodule sizes to define a positive CT lung cancer screening examination.

Gierada DS, Pinsky P, Nath H, Chiles C, Duan F, Aberle DR.

J Natl Cancer Inst. 2014 Oct 18;106(11). pii: dju284. doi: 10.1093/jnci/dju284. Print 2014 Nov.


Lung cancer risk by years since quitting in 30+ pack year smokers.

Pinsky PF, Zhu CS, Kramer BS.

J Med Screen. 2015 Sep;22(3):151-7. doi: 10.1177/0969141315579119. Epub 2015 Apr 29.


Baseline results of the Depiscan study: a French randomized pilot trial of lung cancer screening comparing low dose CT scan (LDCT) and chest X-ray (CXR).

Blanchon T, Bréchot JM, Grenier PA, Ferretti GR, Lemarié E, Milleron B, Chagué D, Laurent F, Martinet Y, Beigelman-Aubry C, Blanchon F, Revel MP, Friard S, Rémy-Jardin M, Vasile M, Santelmo N, Lecalier A, Lefébure P, Moro-Sibilot D, Breton JL, Carette MF, Brambilla C, Fournel F, Kieffer A, Frija G, Flahault A; Dépiscan Group.

Lung Cancer. 2007 Oct;58(1):50-8. Epub 2007 Jul 12.


The clinical effectiveness and cost-effectiveness of primary human papillomavirus cervical screening in England: extended follow-up of the ARTISTIC randomised trial cohort through three screening rounds.

C Kitchener H, Canfell K, Gilham C, Sargent A, Roberts C, Desai M, Peto J.

Health Technol Assess. 2014 Apr;18(23):1-196. doi: 10.3310/hta18230.


Results of the two incidence screenings in the National Lung Screening Trial.

Aberle DR, DeMello S, Berg CD, Black WC, Brewer B, Church TR, Clingan KL, Duan F, Fagerstrom RM, Gareen IF, Gatsonis CA, Gierada DS, Jain A, Jones GC, Mahon I, Marcus PM, Rathmell JM, Sicks J; National Lung Screening Trial Research Team.

N Engl J Med. 2013 Sep 5;369(10):920-31. doi: 10.1056/NEJMoa1208962.


Targeting of low-dose CT screening according to the risk of lung-cancer death.

Kovalchik SA, Tammemagi M, Berg CD, Caporaso NE, Riley TL, Korch M, Silvestri GA, Chaturvedi AK, Katki HA.

N Engl J Med. 2013 Jul 18;369(3):245-54. doi: 10.1056/NEJMoa1301851.


The Relations Between False Positive and Negative Screens and Smoking Cessation and Relapse in the National Lung Screening Trial: Implications for Public Health.

Clark MA, Gorelick JJ, Sicks JD, Park ER, Graham AL, Abrams DB, Gareen IF.

Nicotine Tob Res. 2016 Jan;18(1):17-24. doi: 10.1093/ntr/ntv037. Epub 2015 Mar 6.


Screening for lung cancer. Too many uncertainties, even for smokers.

[No authors listed]

Prescrire Int. 2014 Jan;23(145):19-23. Review.


Cumulative incidence of false-positive results in repeated, multimodal cancer screening.

Croswell JM, Kramer BS, Kreimer AR, Prorok PC, Xu JL, Baker SG, Fagerstrom R, Riley TL, Clapp JD, Berg CD, Gohagan JK, Andriole GL, Chia D, Church TR, Crawford ED, Fouad MN, Gelmann EP, Lamerato L, Reding DJ, Schoen RE.

Ann Fam Med. 2009 May-Jun;7(3):212-22. doi: 10.1370/afm.942.


Screening for lung cancer.

Manser R, Lethaby A, Irving LB, Stone C, Byrnes G, Abramson MJ, Campbell D.

Cochrane Database Syst Rev. 2013 Jun 21;(6):CD001991. doi: 10.1002/14651858.CD001991.pub3. Review.


The Danish randomized lung cancer CT screening trial--overall design and results of the prevalence round.

Pedersen JH, Ashraf H, Dirksen A, Bach K, Hansen H, Toennesen P, Thorsen H, Brodersen J, Skov BG, Døssing M, Mortensen J, Richter K, Clementsen P, Seersholm N.

J Thorac Oncol. 2009 May;4(5):608-14. doi: 10.1097/JTO.0b013e3181a0d98f.

Items per page

Supplemental Content

Write to the Help Desk